Annuncio pubblicitario
Italia markets closed
  • FTSE MIB

    29.928,45
    +191,07 (+0,64%)
     
  • Dow Jones

    36.245,50
    +294,61 (+0,82%)
     
  • Nasdaq

    14.305,03
    +78,81 (+0,55%)
     
  • Nikkei 225

    33.431,51
    -55,38 (-0,17%)
     
  • Petrolio

    74,38
    -1,58 (-2,08%)
     
  • Bitcoin EUR

    36.316,98
    +660,18 (+1,85%)
     
  • CMC Crypto 200

    802,76
    +11,20 (+1,41%)
     
  • Oro

    2.091,70
    +34,50 (+1,68%)
     
  • EUR/USD

    1,0885
    -0,0008 (-0,08%)
     
  • S&P 500

    4.594,63
    +26,83 (+0,59%)
     
  • HANG SENG

    16.830,30
    -212,58 (-1,25%)
     
  • Euro Stoxx 50

    4.418,51
    +36,04 (+0,82%)
     
  • EUR/GBP

    0,8563
    -0,0057 (-0,66%)
     
  • EUR/CHF

    0,9456
    -0,0074 (-0,78%)
     
  • EUR/CAD

    1,4687
    -0,0076 (-0,51%)
     

Notification of managers’ transactions

Chemometec A/S
Chemometec A/S

ANNOUNCEMENT NO. 244

14 September 2023


Notification of managers’ transactions


ChemoMetec A/S has received the enclosed notification pursuant to Article 19 of EU Regulation no. 596/2014 of transactions related to shares in ChemoMetec A/S made by persons discharging managerial responsibilities in ChemoMetec A/S and/or persons closely associated with them.

See the transactions of CEO Rasmus Kofoed in the attached PDF document.


For further information, please contact:

Niels Høy Nielsen, CFO
Telephone (+45) 2551 8724


About ChemoMetec A/S

ChemoMetec develops, manufactures and markets instruments for cell counting and a wide range of other measurements.
ChemoMetec’s instruments are marketed to the pharmaceutical, biotech and agricultural industries worldwide. ChemoMetec’s customers include some of the world’s leading pharmaceutical companies, such as Novartis, Novo Nordisk, H. Lundbeck, Merck, AstraZeneca and Johnson & Johnson.

ChemoMetec was founded in 1997 and is listed on Nasdaq OMX Copenhagen. For further information, go to www.chemometec.com.

Attachment